The Artima Developer Community
Sponsored Link

Java Buzz Forum
Boston Scientific to pay Johnson & Johnson $1.73 billion to settle 2 suits over stents

0 replies on 1 page.

Welcome Guest
  Sign In

Go back to the topic listing  Back to Topic List Click to reply to this topic  Reply to this Topic Click to search messages in this forum  Search Forum Click for a threaded view of the topic  Threaded View   
Previous Topic   Next Topic
Flat View: This topic has 0 replies on 1 page
Angsuman Chakraborty

Posts: 19816
Nickname: angsuman
Registered: Dec, 2003

Angsuman Chakraborty is the CEO and Chief Architect at Taragana
Boston Scientific to pay Johnson & Johnson $1.73 billion to settle 2 suits over stents Posted: Feb 1, 2010 10:40 AM
Reply to this message Reply

This post originated from an RSS feed registered with Java Buzz by Angsuman Chakraborty.
Original Post: Boston Scientific to pay Johnson & Johnson $1.73 billion to settle 2 suits over stents
Feed Title: Simple Thoughts - Java and Web Technology Blog
Feed URL: http://tech.gaeatimes.com/index.php/feed/
Feed Description: News and views as a Software Architect and Entrepreneur on Java and Web Software.
Latest Java Buzz Posts
Latest Java Buzz Posts by Angsuman Chakraborty
Latest Posts From Simple Thoughts - Java and Web Technology Blog

Advertisement
Boston Scientific to pay JNJ $1.73B in settlement WASHINGTON — Boston Scientific said Monday it will pay medical device rival Johnson and Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents. Boston Scientific will pay Johnson & Johnson's Cordis unit $1 billion Monday and $725 million next January. The settlement resolves three patent disputes .... Source  : Boston Scientific to pay Johnson & Johnson $1.73 billion to settle 2 suits over stents.

Read: Boston Scientific to pay Johnson & Johnson $1.73 billion to settle 2 suits over stents

Topic: AT&T adds 2.7 million wireless customers, blowing past Verizon with e-reader help Previous Topic   Next Topic Topic: Motorola posts 4th-quarter profit as costs fall but outlook is below expectations; shares fall

Sponsored Links



Google
  Web Artima.com   

Copyright © 1996-2019 Artima, Inc. All Rights Reserved. - Privacy Policy - Terms of Use